These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 36033885)

  • 1. Microbiota and COVID-19: Long-term and complex influencing factors.
    Gang J; Wang H; Xue X; Zhang S
    Front Microbiol; 2022; 13():963488. PubMed ID: 36033885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions.
    Wang B; Zhang L; Wang Y; Dai T; Qin Z; Zhou F; Zhang L
    Signal Transduct Target Ther; 2022 Apr; 7(1):143. PubMed ID: 35487886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.
    He Y; Wang J; Li F; Shi Y
    Front Microbiol; 2020; 11():1302. PubMed ID: 32582134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome.
    Moreno-Corona NC; López-Ortega O; Pérez-Martínez CA; Martínez-Castillo M; De Jesús-González LA; León-Reyes G; León-Juárez M
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
    Xiang Z; Koo H; Chen Q; Zhou X; Liu Y; Simon-Soro A
    J Oral Microbiol; 2020 Nov; 13(1):1853451. PubMed ID: 33312449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Associations Between Microbiome and COVID-19.
    Wang H; Wang H; Sun Y; Ren Z; Zhu W; Li A; Cui G
    Front Med (Lausanne); 2021; 8():785496. PubMed ID: 35004750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
    Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
    World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic.
    Jabczyk M; Nowak J; Hudzik B; Zubelewicz-Szkodzińska B
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
    Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
    Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis.
    Yu Z; Yang Z; Wang Y; Zhou F; Li S; Li C; Li L; Zhang W; Li X
    Heliyon; 2021 Jul; 7(7):e07548. PubMed ID: 34296023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Chinese medicine against COVID-19: Role of the gut microbiota.
    Yang Z; Liu Y; Wang L; Lin S; Dai X; Yan H; Ge Z; Ren Q; Wang H; Zhu F; Wang S
    Biomed Pharmacother; 2022 May; 149():112787. PubMed ID: 35279010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.